Short-Term Effect of Vitamin K Administration on Prednisolone-Induced Loss of Bone Mineral Density in Patients with Chronic Glomerulonephritis
The DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.
Abstract
Glucocorticoid-induced osteoporosis has been reported to be caused by enhanced bone resorption and suppressed bone formation. To clarify whether administration of vitamin K, which enhances bone formation, prevents prednisolone-induced loss of bone mineral density (BMD), a randomized, prospective, controlled study was conducted on 20 patients with chronic glomerulonephritis scheduled for treatment with prednisolone. All patients were initially treated with 0.8 mg/kg body weight/day of prednisolone (maximum of 40 mg) for 4 weeks, tapering to 20 mg/day over approximately 6 weeks. Ten patients received prednisolone alone (Group 1), and the other 10 patients received prednisolone plus 15 mg of menatetrenone, vitamin K, three times per day (Group 2). BMD of the lumbar spine measured by dual-energy X-ray absorptiometry (DXA) and biochemical markers of bone metabolism in blood and urine were evaluated before and 10 weeks after administration of prednisolone alone or with menatetrenone. In Group 1, treatment with prednisolone significantly reduced BMD of the lumbar spine from 1.14 +/- 0.12 to 1.10 +/- 0.11 g/cm2 (P = 0.0029). Serum intact osteocalcin and procollagen type I C-peptide (PICP) concentrations, biochemical markers of bone formation, were markedly reduced. A biochemical marker of bone resorption, urinary excretion of deoxypyridinoline, was significantly reduced. In Group 2, prednisolone-induced reduction of BMD was prevented by menatetrenone administration (1.09 +/- 0.09 to 1.07 +/- 0.07 g/cm2, P = 0.153). Menatetrenone prevented reduction of PICP concentration by prednisolone but not in serum intact osteocalcin concentration and urinary excretion of deoxypyridinoline. Thus, treatment with prednisolone resulted in loss of BMD of the lumbar spine associated with suppression of both bone formation and bone resorption. Menatetrenone is a useful agent in preventing prednisolone-induced loss of BMD.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Conflicting data exist; in some studies, vitamin K antagonists demonstrate no differences in BMD or fracture rates461, while other data suggest lessening of steroid-induced BMD462 and sex-specific improvements in insulin sensitivity463.”
From Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies (2018) · cites this paper as [462]
Citations
Cites
Prevention of Corticosteroid Osteoporosis -- A Comparison of Calcium, Calcitriol, and Calcitonin
Sambrook, P., Birmingham, J., Kelly, P., Kempler, S., Nguyen, T., Pocock, N., & Eisman, J. (1993) · New England Journal of Medicine · doi:10.1056/nejm199306173282404 · Cited by 520 · cited 1×
“Pharmacological doses of vitamin D may cause acute renal failure secondary to hypercalcemia associated with vitamin D intoxication [17, 21].”
BackgroundHahn, T. J., Halstead, L. R., Teitelbaum, S. L., & Hahn, B. H. (1979) · Journal of Clinical Investigation · doi:10.1172/jci109506 · Cited by 399 · cited 1×
“Bone resorption was stimulated by glucocorticoids in some studies [1, 2, 5, 6], but inhibited in others [7–9].”
ResultTestosterone Therapy in Glucocorticoid-Treated Men
Reid, I. R. (1996) · Archives of Internal Medicine · doi:10.1001/archinte.1996.00440100065008 · Cited by 365
Dempster, D. W., Arlot, M. A., & Meunier, P. J. (1983) · Calcified Tissue International · doi:10.1007/bf02405069 · Cited by 233
ELECTROCHEMICAL DETECTION OF DEPRESSED CIRCULATING LEVELS OF VITAMIN K1IN OSTEOPOROSIS
HART, J. P., SHEARER, M. J., KLENERMAN, L., CATTERALL, A., REEVE, J., SAMBROOK, P. N., DODOS, R. A., BITENSKY, L., & CHAYEN, J. (1985) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-60-6-1268 · Cited by 165 · cited 1×
“Circulating levels of vitamin K in osteoporotic patients are significantly lower than those in age-matched control subjects [13, 14].”
BackgroundEffect of Glucocorticoids on Bone Resorption in Tissue Culture
RAISZ, L. G., TRUMMEL, C. L., WENER, J. A., & SIMMONS, H. (1972) · Endocrinology · doi:10.1210/endo-90-4-961 · Cited by 160
Koshihara, Y., & Hoshi, K. (1997) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.1997.12.3.431 · Cited by 147 · cited 1×
“Vitamin K has been reported to enhance bone formation in in vitro studies [10, 11].”
BackgroundHodges, S. J., Pilkington, M. J., Stamp, T. C. B., Catterall, A., Shearer, M. J., Bitensky, L., & Chayen, J. (1991) · Bone · doi:10.1016/8756-3282(91)90027-g · Cited by 143 · cited 1×
“Circulating levels of vitamin K in osteoporotic patients are significantly lower than those in age-matched control subjects [13, 14].”
BackgroundStruys, A., Snelder, A. A., & Mulder, H. (1995) · The American Journal of Medicine · doi:10.1016/s0002-9343(99)80154-5 · Cited by 135
BONE FORMATION IN HYPERCORTISONISM
Jowsey, J., & Riggs, B. L. (1970) · Acta Endocrinologica · doi:10.1530/acta.0.0630021 · Cited by 134 · cited 1×
“Bone resorption was stimulated by glucocorticoids in some studies [1, 2, 5, 6], but inhibited in others [7–9].”
Result
Cited by
Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies
Batsis, J. A., & Villareal, D. T. (2018) · Nature Reviews Endocrinology · doi:10.1038/s41574-018-0062-9 · Cited by 1,382
Weber, P. (2001) · Nutrition · doi:10.1016/s0899-9007(01)00709-2 · Cited by 197
Role of vitamin K and Gla proteins in the pathophysiology of osteoporosis and vascular calcification
Shearer, M. J. (2000) · Current Opinion in Clinical Nutrition and Metabolic Care · doi:10.1097/00075197-200011000-00004 · Cited by 183
Immunosuppressive agents for treating IgA nephropathy
Vecchio, M., Bonerba, B., Palmer, S. C., Craig, J. C., Ruospo, M., Samuels, J., Molony, D. A., Schena, F. P., & Strippoli, G. F. (2015) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003965.pub2 · Cited by 119
Emaus, N., Gjesdal, C. G., Almås, B., Christensen, M., Grimsgaard, A. S., Berntsen, G. K. R., Salomonsen, L., & Fønnebø, V. (2010) · Osteoporosis International · doi:10.1007/s00198-009-1126-4 · Cited by 102
Immunosuppressive agents for treating IgA nephropathy
Natale, P., Palmer, S. C., Ruospo, M., Saglimbene, V. M., Craig, J. C., Vecchio, M., Samuels, J., Molony, D. A., Schena, F. P., & Strippoli, G. F. (2020) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003965.pub3 · Cited by 104
Bone Health and Osteoporosis: The Role of Vitamin K and Potential Antagonism by Anticoagulants
Pearson, D. A. (2007) · Nutrition in Clinical Practice · doi:10.1177/0115426507022005517 · Cited by 97
Secondary osteoporosis: Underlying disease and the risk for glucocorticoid-induced osteoporosis
Boling, E. P. (2004) · Clinical Therapeutics · doi:10.1016/s0149-2918(04)90001-x · Cited by 98
Glucocorticoid-induced osteoporosis: a review on pathophysiology and treatment options.
de Nijs, R. N. J. (2008) · PubMed · Cited by 87
Regulation of bone remodeling by vitamin K2
Myneni, V. D., & Mezey, É. (2017) · Oral Diseases · doi:10.1111/odi.12624 · Cited by 71
“This combination also protected against bone loss in patients with chronic glomerulonephritis receiving steroid treatments (Yonemura et al, 2000; Tanaka and Oshima, 2007).”
BackgroundSasaki, N., Kusano, E., Takahashi, H., Ando, Y., Yano, K., Tsuda, E., & Asano, Y. (2004) · Journal of Bone and Mineral Metabolism · doi:10.1007/s00774-004-0539-6 · Cited by 64
“In clinical studies, it has been found that vitamin K2 effectively prevents fractures and sustains lumbar BMD in patients with osteoporosis [12] and also prevents GC-induced bone loss [20].”
BackgroundSasaki, N., Kusano, E., Ando, Y., Nemoto, J., Iimura, O., Ito, C., Takeda, S., Yano, K., Tsuda, E., & Asano, Y. (2002) · Bone · doi:10.1016/s8756-3282(02)00742-1 · Cited by 67
Vitamin K2 in bone metabolism and osteoporosis.
Plaza, S. M., & Lamson, D. W. (2005) · PubMed · Cited by 59
Effects of vitamin K on calcium and bone metabolism
Zittermann, A. (2001) · Current Opinion in Clinical Nutrition & Metabolic Care · doi:10.1097/00075197-200111000-00003 · Cited by 61
Ikeda, S., Morishita, Y., Tsutsumi, H., Ito, M., Shiraishi, A., Arita, S., Akahoshi, S., Narusawa, K., & Nakamura, T. (2003) · Bone · doi:10.1016/s8756-3282(03)00263-1 · Cited by 53
“Similar results were obtained in adults treated with oral GCs [34,35].”
ResultGlucocorticoid-Induced Osteoporosis
Lukert, B. P. (1992) · Southern Medical Journal · doi:10.1097/00007611-199208001-00009 · Cited by 42
Güler, E., Baripoglu, Y. E., Alenezi, H., Arikan, A., Babazade, R., Ünal, S., Duruksu, G., Alfares, F. S., Yazır, Y., Oktar, F. N., et al. (2021) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2021.08.196 · Cited by 37
Immunomodulatory effect of vitamin K2: Implications for bone health
Myneni, V. D., & Mezey, É. (2018) · Oral Diseases · doi:10.1111/odi.12759 · Cited by 34
“bone health of women with post-menopausal osteoporosis has been studied by a number of clinical investigators (Inoue et al., 2009; Iwamoto et al., 2003; Knapen et al., 2007; Tanaka and Oshima, 2007; Ushiroyama et al., 2002; Yonemura et al., 2004; Yonemura et al., 2000).”
BackgroundTreatment of glucocorticoid‐induced low bone mineral density in children: a systematic review
Jayasena, A., Atapattu, N., & Lekamwasam, S. (2015) · International Journal of Rheumatic Diseases · doi:10.1111/1756-185x.12560 · Cited by 34
Effect of menatetrenone (vitamin K2) treatment on bone loss in patients with anorexia nervosa
Iketani, T., Kiriike, N., Stein, M. B., Nagao, K., Nagata, T., Minamikawa, N., Shidao, A., & Fukuhara, H. (2003) · Psychiatry Research · doi:10.1016/s0165-1781(03)00024-6 · Cited by 31
Yonemura, K., Fukasawa, H., Fujigaki, Y., & Hishida, A. (2004) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2003.09.013 · Cited by 29
Self-citationPrevention and treatment of glucocorticoid-induced osteoporosis
Curtis, J. R., & Saag, K. G. (2007) · Current Osteoporosis Reports · doi:10.1007/bf02938618 · Cited by 30
“One prospective study attempted to demonstrate the efficacy of vitamin K in reducing glucocorticoid-associated bone loss and to elucidate its mechanism of action [ 48 ,49].”
BackgroundInoue, T., Sugiyama, T., Matsubara, T., Kawai, S., & Furukawa, S. (2001) · Endocrine Journal · doi:10.1507/endocrj.48.11 · Cited by 28
Glucocorticoid-Induced Osteoporosis
Adler, R. A., Curtis, J. R., Weinstein, R. S., & Saag, K. G. (2008) · Elsevier eBooks · doi:10.1016/b978-012370544-0.50046-x · Cited by 31
The effect of methotrexate on bone metabolism markers in patients with rheumatoid arthritis
Torikai, E., Kageyama, Y., Takahashi, M., & Nagano, A. (2006) · Modern Rheumatology · doi:10.1007/s10165-006-0517-z · Cited by 27
Effects of Vitamin K2 on the Development of Osteopenia in Rats as the Models of Osteoporosis
Iwamoto, J., Takeda, T., & Satō, Y. (2006) · Yonsei Medical Journal · doi:10.3349/ymj.2006.47.2.157 · Cited by 27
Non-immunosuppressive treatment for IgA nephropathy
Tunnicliffe, D. J., Reid, S. E., Craig, J. C., Samuels, J., Molony, D. A., & Strippoli, G. F. (2024) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003962.pub3 · Cited by 31
Glucocorticoid-Induced Osteoporosis
Lukert, B. P. (2004) · Humana Press eBooks · doi:10.1007/978-1-59259-740-6_36 · Cited by 19
Solmaz, İ., Özdemir, M. A., Ünal, E., Abdurrezzak, Ü., Muhtaroğlu, S., & Karakükçü, M. (2021) · Journal of Pediatric Endocrinology and Metabolism · doi:10.1515/jpem-2020-0637 · Cited by 18
Onodera, K., Takahashi, A., Wakabayashi, H., Kamei, J., & Sakurada, S. (2003) · Nutrition · doi:10.1016/s0899-9007(02)00962-0 · Cited by 18
Emaus, N., Nguyen, N. D., Almaas, B., Berntsen, G. K., Center, J. R., Christensen, M., Gjesdal, C. G., Grimsgaard, A. S., Nguyen, T. V., Salomonsen, L., et al. (2013) · European Journal of Nutrition · doi:10.1007/s00394-011-0285-1 · Cited by 15
Ohashi, N., Yonemura, K., Hirano, M., Takahashi, S., Kato, A., Fujigaki, Y., Yamamoto, T., & Hishida, A. (2002) · Internal Medicine · doi:10.2169/internalmedicine.41.1171 · Cited by 12
Self-citationEffect of vitamin K2 on cortical and cancellous bones in orchidectomized young rats
Iwamoto, J., Takeda, T., Yeh, J. K., Ichimura, S., & Toyama, Y. (2003) · Maturitas · doi:10.1016/s0378-5122(02)00315-8 · Cited by 13
Hamano, T., Fujii, N., Nagasawa, Y., Isaka, Y., Moriyama, T., Okada, N., Imai, E., Horio, M., & Ito, T. (2006) · Bone · doi:10.1016/j.bone.2006.04.022 · Cited by 10
“By contrast, there are few reports addressing the effects of drugs on bone turnover markers in GIO except for those of vitamin K [6] and parathyroid hormone [7].”
BackgroundRETRACTED ARTICLE: Menatetrenone for the treatment of osteoporosis
Iwamoto, J., & Satō, Y. (2013) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2013.763796 · Cited by 10
“[26] Patients with chronic glomerulonephritis scheduled for glucocorticoid (20) Open-label RCT in Japan (45 mg, 10 weeks) Lumbar spine BMD was maintained Menatetrenone: -1.”
BackgroundRetractedShikano, K., Kaneko, K., Kawazoe, M., Kaburaki, M., Hasunuma, T., & Kawai, S. (2016) · Internal Medicine · doi:10.2169/internalmedicine.55.6230 · Cited by 9
The Anti-osteoporosis Effects of Vitamin K in Postmenopausal Women
Liu, Y., He, Y., He, B., & Kong, L. (2021) · Current Stem Cell Research & Therapy · doi:10.2174/1574888x16666210512020103 · Cited by 7
Kürkçü, M., Öz, İ. A., & Benlidayı, M. E. (2005) · Archives of Oral Biology · doi:10.1016/j.archoralbio.2005.02.006 · Cited by 7
Ai, J., Guo, Z., & Liu, W. (2021) · New Journal of Chemistry · doi:10.1039/d1nj00277e · Cited by 7
The Role of Vitamin K in Bone Remodeling and Osteoporosis
Giammanco, M., Majo, D. D., Leto, G., Flandina, C., Piazza, M. D., & Guardia, M. L. (2012) · Journal of Food Research · doi:10.5539/jfr.v1n4p106 · Cited by 6
Glucocorticoid-Induced Osteoporosis
Adler, R. A., Weinstein, R. S., & Saag, K. G. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-415853-5.00049-2 · Cited by 6
Çadir, B., Kürkçü, M., Öz, İ. A., & Benlidayı, M. E. (2009) · Archives of Oral Biology · doi:10.1016/j.archoralbio.2009.02.001 · Cited by 5
New Insights on the Pathogenesis of Hypercalcemia in Primary Hyperparathyroidism
Yonemura, K., Suzuki, H., Fujigaki, Y., & Hishida, A. (2000) · The American Journal of the Medical Sciences · doi:10.1097/00000441-200011000-00007 · Cited by 5
Self-citationVitamin K2 supplementation in haemodialysis patients
Hargreaves, I. P., & Mantle, D. (2018) · Journal of Kidney Care · doi:10.12968/jokc.2018.3.6.368 · Cited by 3
Vitamine K et os : quelle relation ?
Pressac, M., & Moussa, F. (2003) · Immuno-analyse & Biologie Spécialisée · doi:10.1016/s0923-2532(03)00077-2 · Cited by 3
Vitamine K et physiologie osseuse
Coxam, V., Davicco, M.-J., Wauquier, F., & Wittrant, Y. (2009) · Cahiers de Nutrition et de Diététique · doi:10.1016/j.cnd.2009.03.005 · Cited by 5
Neustadt, J. O., & Pieczenik, S. R. (2012) · Cited by 1
GLUCOCORTICOIDS AND DISEASE – MODIFYING ANTIRHEUMATIC DRUGS
(2010) · Elsevier eBooks · doi:10.1016/b978-0-444-53273-2.50007-9 · Cited by 1
39 Corticotrophins, corticosteroids, and prostaglandins
Costa, J., & Farré, M. (2007) · Side effects of drugs annual · doi:10.1016/s0378-6080(06)29039-1
Evolving role of vitamin K2-7(Menaquinone) in Osteoporosis & cardiovascular health
A, F. A. A. M. A. (2014) · International Journal of Pharmacological Research · doi:10.7439/ijpr.v4i2.90
NUTRITION AND OSTEOPOROSIS IN CHILDHOOD
Kara, İ. H., & Haspolat, K. (2003) · Turkish Journal of Family Practice
Sample size and study interpretation
Pittler, M. H. (2004) · Canadian Medical Association Journal · doi:10.1503/cmaj.1040153
Wilson, R. (2004) · Canadian Medical Association Journal · doi:10.1503/cmaj.1031201
Atkinson, S. A. (2004) · Canadian Medical Association Journal · doi:10.1503/cmaj.1031096
Sample size and study interpretation
Leung, F. C.-C. (2004) · Canadian Medical Association Journal · doi:10.1503/cmaj.1040023
Witamina K i jej rola w profilaktyce chorób dzieci w świetle nowych doniesień
Kozioł-Kozakowska, A., Stochel-Gaudyn, A., & Fyderek, K. (2016) · Pediatria Polska · doi:10.1016/j.pepo.2016.03.003
Vitamin K, osteoporose og warfarin
Singsaas, E. G. (2006) · NORA - Norwegian Open Research Archives · Cited by 1
Glucocorticoid-induced osteoporosis and Cushing’s syndrome
Saag, K. G., Adler, R. A., & Weinstein, R. S. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-813073-5.00045-9 · Cited by 1
Corticosteroids—glucocorticoids
(2006) · Elsevier eBooks · doi:10.1016/b0-44-451005-2/00932-3
CORTICOSTEROIDS AND PROSTAGLANDINS
(2010) · Elsevier eBooks · doi:10.1016/b978-0-444-53267-1.50005-8
Corticotrophins, corticosteroids, and prostaglandins
Costa, J. C., & Farré, M. (2002) · Side effects of drugs annual · doi:10.1016/s0378-6080(02)80046-0
CORTICOSTEROIDS AND RELATED DRUGS
(2009) · Elsevier eBooks · doi:10.1016/b978-0-444-53271-8.50004-1
Corticosteroids—glucocorticoids
(2015) · Elsevier eBooks · doi:10.1016/b978-0-444-53717-1.00549-7
Effect of vitamin K on musculoskeletal health in postmenopausal women
Jan, R., & Stančíková, M. (2019) · Clinical Osteology · doi:10.36290/clo.2019.001
Metadata
- Authors
- Yonemura, K., Kimura, M., Miyaji, T., & Hishida, A.
- Affiliations
- Hamamatsu University (JP)
- Shizuoka University (JP)
- ORCID
- Kimura, M.
- Venue
- Calcified Tissue International
- Published
- 2000-02
- Volume
- 66
- Issue
- 2
- Pages
- 123-128
- ISSN
- 0171-967X (ISSN-L)
- OpenAlex
- W2034789148
- Cited by
- 64
- References
- 22
- Citations by year
- 2024: 1 · 2021: 4 · 2020: 2 · 2019: 1 · 2018: 3 · 2016: 3 · 2015: 3 · 2014: 1 · 2013: 2 · 2012: 2
- FWCI
- 4.63
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Calcified Tissue International (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Nursing › Nutrition and Dietetics › Vitamin K Research Studies
- Health Sciences › Medicine › Orthopedics and Sports Medicine › Bone health and osteoporosis research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Vitamin D Research Studies
- Keywords
- vitamin K, menatetrenone, prednisolone, glucocorticoid-induced osteoporosis, bone mineral density, chronic glomerulonephritis, bone formation, bone resorption, osteocalcin, deoxypyridinoline, lumbar spine
- MeSH terms
- Adolescent, Adult, Anti-Inflammatory Agents, Calcium, Chronic Disease, Drug Therapy, Combination, Female, Glomerulonephritis, Hemostatics, Humans, Male, Middle Aged, Osteoporosis, Phosphates, Prednisolone, Vitamin K, Absorptiometry, Photon, Bone Density, Vitamin K 2
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.